环球医疗器械 GMED
$71.05 −$10.39 (-12.76%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $71.20 +0.21%
开盘$74.10
昨收$81.44
当日区间$70.40 – $75.63
成交量9.27M
市值$9.41B
市盈率（TTM）17.5
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$789.61M+5.9% YoY
营业利润$195.47M+59.2% YoY
净利润$151.57M-25.3% YoY
摊薄每股收益$1.10-26.2% YoY
自由现金流$176.57M+464.1% YoY
经营现金流$209.74M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率68.5%
营业利润率21.4%
净利率17.0%
净资产收益率11.8%
资产收益率10.2%
投入资本回报率11.5%
流动比率4.62
负债/资产比率13.1%
现金及投资$595.14M
总负债$96.81M
净现金（净负债）$498.34M
自由现金流/营收23.7%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $789.61M | $759.85M | $2.94B | $826.42M | $769.05M |
| 营业总收入 | $789.61M | $759.85M | $2.94B | $826.42M | $769.05M |
| 营业成本 | $241.44M | $234.07M | $957.80M | $261.11M | $252.53M |
| 毛利润 | $548.17M | $525.79M | $1.98B | $565.31M | $516.52M |
| 营业费用 | $352.70M | $363.81M | $1.44B | $384.00M | $381.51M |
| 销售及管理费用 | $286.82M | $297.78M | $1.18B | $318.48M | $313.60M |
| 研发费用 | $36.32M | $36.51M | $147.25M | $36.16M | $38.07M |
| 折旧、摊销与折耗 | $29.56M | $29.53M | $118.19M | $29.36M | $29.84M |
| -折旧与摊销 | $29.56M | $29.53M | $118.19M | $29.36M | $29.84M |
| 营业利润 | $195.47M | $161.98M | $537.19M | $181.31M | $135.01M |
| 非经营性利息净收入（支出） | $7.07M | $5.43M | $7.14M | $3.31M | $1.46M |
| 其他财务成本合计 | -$7.07M | -$5.43M | -$7.14M | -$3.31M | -$1.46M |
| 其他收入（支出） | -$12.73M | -$10.34M | $60.74M | -$15.39M | $7.53M |
| 证券出售收益 | -$860,000.00 | -$2.11M | -$3.01M | -$7.15M | -$161,000.00 |
| 特殊收益（费用） | -$13.04M | -$10.47M | $60.33M | -$8.63M | $6.16M |
| -减：重组及并购费用 | $13.04M | $10.47M | -$60.33M | $8.63M | -$6.16M |
| 其他非经营性收入（支出） | $1.17M | $2.25M | $3.41M | $391,000.00 | $1.54M |
| 税前利润 | $189.82M | $157.07M | $605.07M | $169.23M | $143.99M |
| 税费 | $38.25M | $32.77M | $67.20M | $28.64M | $25.03M |
| 净利润 | $151.57M | $124.30M | $537.87M | $140.59M | $118.97M |
| 持续经营利润 | $151.57M | $124.30M | $537.87M | $140.59M | $118.97M |
| 归属母公司净利润 | $151.57M | $124.30M | $537.87M | $140.59M | $118.97M |
| 归属普通股股东净利润 | $151.57M | $124.30M | $537.87M | $140.59M | $118.97M |
| 基本每股收益 | $1.12 | $0.92 | $3.98 | $1.05 | $0.88 |
| 摊薄每股收益 | $1.10 | $0.90 | $3.92 | $1.03 | $0.88 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $5.49B | $5.44B | $5.30B | $5.30B | $5.10B |
| 流动资产合计 | $2.22B | $2.20B | $2.13B | $2.13B | $1.92B |
| 现金及现金等价物与短期投资 | $595.14M | $629.85M | $557.24M | $557.24M | $390.52M |
| -现金及现金等价物 | $507.75M | $560.95M | $526.16M | $526.16M | $371.77M |
| -短期投资 | $87.40M | $68.90M | $31.09M | $31.09M | $18.75M |
| 应收款 | $739.28M | $735.44M | $743.67M | $743.67M | $688.12M |
| -应收账款 | $692.18M | $686.43M | $678.94M | $678.94M | $619.12M |
| -应收税款 | $47.10M | $49.01M | $64.73M | $64.73M | $69.01M |
| 存货 | $810.90M | $772.60M | $759.28M | $759.28M | $771.54M |
| 其他流动资产 | $70.20M | $60.23M | $65.43M | $65.43M | $74.18M |
| 非流动资产合计 | $3.27B | $3.24B | $3.18B | $3.18B | $3.17B |
| 固定资产净值 | $592.68M | $618.65M | $628.24M | $628.24M | $637.20M |
| -固定资产原值 | $1.36B | $1.37B | $1.33B | $1.33B | $1.28B |
| -累计折旧 | -$770.09M | -$747.58M | -$705.00M | -$705.00M | -$646.66M |
| 投资及预付款 | $245.36M | $169.44M | $71.82M | $71.82M | $16.68M |
| -可供出售证券 | $140.82M | $89.44M | $34.96M | $34.96M | – |
| -持有至到期证券 | $104.54M | $80.00M | $36.86M | $36.86M | – |
| 商誉及其他无形资产 | $2.13B | $2.16B | $2.18B | $2.18B | $2.21B |
| -商誉 | $1.44B | $1.44B | $1.44B | $1.44B | $1.43B |
| -其他无形资产 | $692.62M | $720.85M | $745.06M | $745.06M | $773.90M |
| 一年以上递延资产 | $224.63M | $214.81M | $218.22M | $218.22M | $232.36M |
| 其他非流动资产 | $79.24M | $78.96M | $78.78M | $78.78M | $76.84M |
| 负债合计 | $719.66M | $707.24M | $729.51M | $729.51M | $696.82M |
| 流动负债合计 | $479.35M | $482.46M | $498.50M | $498.50M | $465.96M |
| 应付款 | $141.84M | $135.83M | $132.25M | $132.25M | $136.55M |
| -应付账款 | $106.94M | $103.66M | $98.85M | $98.85M | $87.23M |
| -应付税款合计 | $34.90M | $32.17M | $33.40M | $33.40M | $49.32M |
| 一年内应计费用 | $133.63M | $137.99M | $137.24M | $137.24M | $120.83M |
| 短期债务及融资租赁负债 | $14.39M | $15.12M | $14.74M | $14.74M | $14.36M |
| -一年内到期融资租赁负债 | $14.39M | $15.12M | $14.74M | $14.74M | $14.36M |
| 一年内递延负债 | $27.98M | $26.35M | $27.66M | $27.66M | $18.27M |
| 其他流动负债 | $23.28M | $20.87M | $19.51M | $19.51M | $18.90M |
| 非流动负债合计 | $240.31M | $224.78M | $231.01M | $231.01M | $230.86M |
| 长期债务及融资租赁负债 | $96.81M | $100.10M | $103.92M | $103.92M | $104.99M |
| -长期融资租赁负债 | $96.81M | $100.10M | $103.92M | $103.92M | $104.99M |
| 一年以上递延负债 | $42.34M | $24.66M | $23.76M | $23.76M | $22.54M |
| 其他非流动负债 | $101.16M | $100.02M | $103.34M | $103.34M | $103.33M |
| 股东权益合计 | $4.77B | $4.73B | $4.57B | $4.57B | $4.40B |
| 股东权益 | $4.77B | $4.73B | $4.57B | $4.57B | $4.40B |
| 股本 | $134,000.00 | $135,000.00 | $135,000.00 | $135,000.00 | $134,000.00 |
| -普通股 | $134,000.00 | $135,000.00 | $135,000.00 | $135,000.00 | $134,000.00 |
| 资本公积 | $3.23B | $3.21B | $3.17B | $3.17B | $3.10B |
| 留存收益 | $1.53B | $1.51B | $1.39B | $1.39B | $1.29B |
| 不影响留存收益的损益 | $11.20M | $14.40M | $15.35M | $15.35M | $10.93M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $209.74M | $202.36M | $753.45M | $248.59M | $249.70M |
| 持续经营经营活动现金流净额 | $209.74M | $202.36M | $753.45M | $248.59M | $249.70M |
| 持续经营净利润 | $151.57M | $124.30M | $537.87M | $140.59M | $118.97M |
| 持续经营损益 | $3.23M | $2.55M | -$66,000.00 | $6.12M | -$972,000.00 |
| 折旧、折耗与摊销 | $69.50M | $69.86M | $276.84M | $69.01M | $71.55M |
| 递延税款 | $7.79M | $7.96M | $18.63M | $18.10M | $41.76M |
| 其他非现金项目 | $9.38M | $2.96M | -$95.15M | $13.34M | -$224,000.00 |
| 营运资金变动 | -$55.07M | -$28.12M | -$66.80M | -$21.51M | $1.74M |
| -应收款变动 | -$13.81M | -$13.40M | -$52.18M | -$64.15M | -$8.42M |
| -存货变动 | -$27.90M | -$16.65M | -$17.60M | -$178,000.00 | -$5.70M |
| -预付资产变动 | -$7.40M | $6.94M | $11.13M | $17.82M | -$7.54M |
| -应付账款及应计费用变动 | -$10.76M | -$19.59M | $42.70M | $17.92M | $42.71M |
| -其他营运资金变动 | $4.81M | $14.58M | -$50.85M | $7.09M | -$19.31M |
| 投资活动现金流净额 | -$129.05M | -$182.67M | -$355.01M | -$111.45M | -$75.84M |
| 持续经营投资活动现金流净额 | -$129.05M | -$182.67M | -$355.01M | -$111.45M | -$75.84M |
| 固定资产购置及出售净额 | -$33.17M | -$39.62M | -$164.68M | -$46.20M | -$35.82M |
| 业务购买及出售净额 | -$1.50M | -$4.91M | -$252.55M | $0.00 | $5.00M |
| 投资购置及出售净额 | -$94.38M | -$138.15M | $71.96M | -$65.17M | -$35.36M |
| 筹资活动现金流 | -$134.50M | $18.20M | -$679.16M | $13.22M | -$32.04M |
| 持续经营筹资活动现金流净额 | -$134.50M | $18.20M | -$679.16M | $13.22M | -$32.04M |
| 债务发行及偿还净额 | $0.00 | $0.00 | -$449.99M | $0.00 | $0.00 |
| 普通股发行净额 | -$136.06M | $0.00 | -$300.45M | -$45.00M | -$40.00M |
| 股票期权行使所得 | $10.97M | $25.96M | $89.76M | $62.76M | $11.08M |
| 其他筹资费用净额 | -$9.41M | -$7.76M | -$18.48M | -$4.54M | -$3.12M |
| 期末现金余额 | $507.75M | $560.95M | $526.16M | $526.16M | $371.77M |
| 现金净变动 | -$53.80M | $37.89M | -$280.73M | $150.35M | $141.81M |
| 期初现金余额 | $560.95M | $526.16M | $784.44M | $371.77M | $229.45M |
| 汇率变动影响 | $598,000.00 | -$3.09M | $22.45M | $4.03M | $512,000.00 |
| 自由现金流 | $176.57M | $162.75M | $579.02M | $202.31M | $204.21M |
| 无形资产购置及出售净额 | – | – | -$9.75M | -$80,000.00 | – |
暂无评论——快来第一个聊聊 GMED。